| 1 |
34496661 | Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice? | 2022 Jan |
2 |
| 2 |
35588934 | Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET. | 2022 May 20 |
2 |
| 3 |
34757711 | Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain. | 2021 Dec 1 |
1 |
| 4 |
32898790 | An original radio-biomimetic approach to synthesize radiometabolites for PET imaging. | 2020 Nov - Dec |
1 |
| 5 |
31322284 | Simultaneous quantification of ondansetron and tariquidar in rat and human plasma using a high performance liquid chromatography-ultraviolet method. | 2019 Nov |
1 |
| 6 |
30130561 | Potentiation of antiseizure and neuroprotective efficacy of standard nerve agent treatment by addition of tariquidar. | 2018 Sep |
1 |
| 7 |
26454782 | 5-HT2A receptor SPECT imaging with [¹²³I]R91150 under P-gp inhibition with tariquidar: More is better? | 2016 Jan |
3 |
| 8 |
26621623 | Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration. | 2016 Feb |
1 |
| 9 |
27287416 | Increasing nerve agent treatment efficacy by P-glycoprotein inhibition. | 2016 Nov 25 |
2 |
| 10 |
23072492 | Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography. | 2012 Oct 16 |
3 |
| 11 |
23143088 | Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET. | 2012 Dec |
2 |
| 12 |
21600273 | Increasing oxime efficacy by blood-brain barrier modulation. | 2011 Sep 25 |
1 |
| 13 |
21677164 | A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier. | 2011 Jun 15 |
3 |
| 14 |
19796699 | Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. | 2010 Jan 15 |
6 |
| 15 |
20016890 | Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET. | 2010 May |
1 |
| 16 |
20633036 | Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy. | 2010 Sep |
1 |
| 17 |
18632828 | Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET. | 2008 Aug |
2 |
| 18 |
18760905 | Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. | 2008 Nov |
1 |
| 19 |
17392402 | Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. | 2007 Jul |
1 |
| 20 |
17437408 | Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. | 2007 Apr |
2 |
| 21 |
16650133 | Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. | 2006 Apr |
1 |
| 22 |
16928449 | The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. | 2006 Oct |
1 |
| 23 |
17027274 | Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. | 2006 Dec |
1 |